VXM01 phase I study in patients with progressive glioblastoma: Final results.

Wolfgang Wick(German Cancer Research Center), Michael Platten(German Cancer Research Center), Sébastien Wieckowski(Centre National de la Recherche Scientifique), Christel Herold‐Mende, Philipp Kickingereder(University of Bonn), Dennis Riehl(Johannes Gutenberg University Mainz), Antje Wick(Heidelberg University), Andreas von Deimling(German Cancer Research Center), Felix Sahm(German Cancer Research Center), Philipp Beckhove(German Cancer Research Center), Christine Jungk, Friedrich H. Schmitz-Winnenthal(Klinikum Aschaffenburg), Andreas Unterberg(Heidelberg University), Lilli Podola(Vaximm (Germany)), Martin Bendszus(Heidelberg University)
Journal of Clinical Oncology
May 20, 2018
Cited by 16


Related Papers